Blue Jet Healthcare has successfully completed commissioning of multi- product Production block to manufacture pharma intermediates at its existing Unit 2 facility situated at Ambernath, Maharashtra, India. The company has commenced manufacturing of Validation Batches with effect from June 29, 2024. The current capacity utilization is around 70% of the existing capacity. The company is proposed to commercialize full scale production within next six months. Total investment incurred is Rs 90 crore.
The Mumbai-based Blue Jet Healthcare is a specialty pharmaceutical and healthcare ingredient and intermediate company, offering niche products targeted towards innovator pharmaceutical companies and multinational generic pharmaceutical companies.
